538 related articles for article (PubMed ID: 30346600)
1. Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
Chiocca EA; Nassiri F; Wang J; Peruzzi P; Zadeh G
Neuro Oncol; 2019 Jan; 21(1):14-25. PubMed ID: 30346600
[TBL] [Abstract][Full Text] [Related]
2. Effects of oncolytic viruses and viral vectors on immunity in glioblastoma.
Liu P; Wang Y; Wang Y; Kong Z; Chen W; Li J; Chen W; Tong Y; Ma W; Wang Y
Gene Ther; 2022 Apr; 29(3-4):115-126. PubMed ID: 33191399
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
Kroeger KM; Muhammad AK; Baker GJ; Assi H; Wibowo MK; Xiong W; Yagiz K; Candolfi M; Lowenstein PR; Castro MG
Discov Med; 2010 Oct; 10(53):293-304. PubMed ID: 21034670
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.
Wollmann G; Ozduman K; van den Pol AN
Cancer J; 2012; 18(1):69-81. PubMed ID: 22290260
[TBL] [Abstract][Full Text] [Related]
5. Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study.
Miller KE; Cassady KA; Roth JC; Clements J; Schieffer KM; Leraas K; Miller AR; Prasad N; Leavenworth JW; Aban IB; Whitley RJ; Gillespie GY; Mardis ER; Markert JM
Clin Cancer Res; 2022 Feb; 28(3):498-506. PubMed ID: 35105718
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial.
Geletneky K; Hajda J; Angelova AL; Leuchs B; Capper D; Bartsch AJ; Neumann JO; Schöning T; Hüsing J; Beelte B; Kiprianova I; Roscher M; Bhat R; von Deimling A; Brück W; Just A; Frehtman V; Löbhard S; Terletskaia-Ladwig E; Fry J; Jochims K; Daniel V; Krebs O; Dahm M; Huber B; Unterberg A; Rommelaere J
Mol Ther; 2017 Dec; 25(12):2620-2634. PubMed ID: 28967558
[TBL] [Abstract][Full Text] [Related]
7. Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas.
Estevez-Ordonez D; Chagoya G; Salehani A; Atchley TJ; Laskay NMB; Parr MS; Elsayed GA; Mahavadi AK; Rahm SP; Friedman GK; Markert JM
Neurosurg Clin N Am; 2021 Apr; 32(2):265-281. PubMed ID: 33781507
[TBL] [Abstract][Full Text] [Related]
8. Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.
Geletneky K; Huesing J; Rommelaere J; Schlehofer JR; Leuchs B; Dahm M; Krebs O; von Knebel Doeberitz M; Huber B; Hajda J
BMC Cancer; 2012 Mar; 12():99. PubMed ID: 22436661
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Poliovirus for Cancer Immunotherapy.
Gromeier M; Nair SK
Annu Rev Med; 2018 Jan; 69():289-299. PubMed ID: 29414253
[TBL] [Abstract][Full Text] [Related]
10. Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.
Kiyokawa J; Kawamura Y; Ghouse SM; Acar S; Barçın E; Martínez-Quintanilla J; Martuza RL; Alemany R; Rabkin SD; Shah K; Wakimoto H
Clin Cancer Res; 2021 Feb; 27(3):889-902. PubMed ID: 33257429
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses.
Alayo QA; Ito H; Passaro C; Zdioruk M; Mahmoud AB; Grauwet K; Zhang X; Lawler SE; Reardon DA; Goins WF; Fernandez S; Chiocca EA; Nakashima H
Sci Rep; 2020 Mar; 10(1):5095. PubMed ID: 32198420
[TBL] [Abstract][Full Text] [Related]
12. Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV.
Mazzacurati L; Marzulli M; Reinhart B; Miyagawa Y; Uchida H; Goins WF; Li A; Kaur B; Caligiuri M; Cripe T; Chiocca EA; Amankulor N; Cohen JB; Glorioso JC; Grandi P
Mol Ther; 2015 Jan; 23(1):99-107. PubMed ID: 25200130
[TBL] [Abstract][Full Text] [Related]
13. Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies.
Haddad AF; Young JS; Mummaneni NV; Kasahara N; Aghi MK
J Neurooncol; 2021 Mar; 152(1):1-13. PubMed ID: 33389564
[TBL] [Abstract][Full Text] [Related]
14. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma.
Kane JR; Miska J; Young JS; Kanojia D; Kim JW; Lesniak MS
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii24-ii36. PubMed ID: 25746089
[TBL] [Abstract][Full Text] [Related]
15. Immune and viral therapies for malignant primary brain tumors.
Gardeck AM; Sheehan J; Low WC
Expert Opin Biol Ther; 2017 Apr; 17(4):457-474. PubMed ID: 28274139
[TBL] [Abstract][Full Text] [Related]
16. Gene therapeutics: the future of brain tumor therapy?
Cutter JL; Kurozumi K; Chiocca EA; Kaur B
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1053-64. PubMed ID: 16831077
[TBL] [Abstract][Full Text] [Related]
17. Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
Patel DM; Foreman PM; Nabors LB; Riley KO; Gillespie GY; Markert JM
Hum Gene Ther Clin Dev; 2016 Jun; 27(2):69-78. PubMed ID: 27314913
[TBL] [Abstract][Full Text] [Related]
18. Recombinant oncolytic poliovirus eliminates glioma in vivo without genetic adaptation to a pathogenic phenotype.
Dobrikova EY; Broadt T; Poiley-Nelson J; Yang X; Soman G; Giardina S; Harris R; Gromeier M
Mol Ther; 2008 Nov; 16(11):1865-72. PubMed ID: 18766173
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy.
Ulasov IV; Shah N; Kaverina NV; Lee H; Lin B; Lieber A; Kadagidze ZG; Yoon JG; Schroeder B; Hothi P; Ghosh D; Baryshnikov AY; Cobbs CS
Oncotarget; 2015 Feb; 6(6):3977-87. PubMed ID: 25738357
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic adenoviral therapy for glioblastoma multiforme.
Sonabend AM; Ulasov IV; Han Y; Lesniak MS
Neurosurg Focus; 2006 Apr; 20(4):E19. PubMed ID: 16709024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
